Blog

Types Of Signal In Pharmacovigilance

03/02/2022

Pharmacovigilance is concerned with detecting the possible risks associated with a drug or treatment. Risks are monitored and assessed throughout the development and post-market phase. The aim of this is to determine the safety profile of the drug, identifying any potential adverse reactions and side effects that the drug may cause. Additionally, any beneficial reactions […]

Read More

What’s the difference between Phase 2 and Phase 3 Clinical Trials?

10/01/2022

In previous years, pharmacology and clinical trials were topics which mainly interested medical professionals, rather than the public. However, as a result of the COVID-19 pandemic, there has been a growing interest in clinical trials, alongside the development of the vaccine. As a global community, we have been  able to see the development, testing, and […]

Read More

What is Clinical Pharmacology and Therapeutics?

24/11/2021

Clinical pharmacology and therapeutics is the science of medicines and how they are used to diagnose, prevent and treat diseases and disorders in humans. Clinical pharmacologists are experts in various aspects of medicinal treatment. They are able to determine the best medicine and dosage for an individual, based on a number of factors. They take […]

Read More

Rare Diseases: Everything you need to know

18/11/2021

In the UK alone, it’s estimated that around 3 million people are living with a rare disease or condition. The effects of these diseases can be wide-ranging and unique, meaning that many of these 3 million people will face challenges the majority of the population are likely never to experience.  There are some conditions where […]

Read More

Lending a Hand to Support Rare Disease Day

17/02/2020

As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from the official campaign suggestion of recreating the Rare Disease Day logo, our staff enthusiastically joined in to produce two canvases made from hundreds of individual handprints. The final recreation of the logo on one of […]

Read More

Improving Patient Engagement In Clinical Trials To Develop New Drugs

17/02/2020

Developing new drugs is a rigorous and detailed process, requiring close scrutiny and testing across clinical trials in order for the drug to successfully find its way to market. The development process is necessary for understanding drug safety and efficacy before it becomes available for public use. And with patients at the heart of clinical […]

Read More

Challenges And Opportunities In Rare Disease Clinical Trials: Putting The Patient First

17/02/2020

Clinical research helps develop new evidence-based approaches to treating health conditions, resulting in better, safer and more effective treatments. However, in the case of studying rare disease treatments, clinical research can be particularly challenging. This can be for a number of reasons, such as the rare disease not being fully understood, a lack of awareness […]

Read More

Got a question?
Get in Touch or Submit an RFI/RFP

Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Name(Required)
Opt In Emails